510(k) device
Access Thyroglobulin
Beckman Coulter, Inc. · System, Test, Thyroglobulin (MSW, Class II) · First FDA decision Oct 19, 2000, newest Jun 28, 2024Thyroid nodules and thyroid disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
510(k) pathway
Device trials
2,701
Naming "Access"
MAUDE reports
24,146
Brand "Access", since 2015
PubMed studies
599,463
Mentioning "Access"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Access Thyroglobulin
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- Access Thyroglobulin510(k)
K240927 · Decided Jun 28, 2024 · 85 days after receipt
Device type: System, Test, Thyroglobulin (MSW) · Laboratory Medicine & Pathology
4 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Seat Elevation Systems as an Accessory to Power Wheelchairs (Group 3)National analysisReview closedCAG-00461NUpdated Sep 23, 2026
- Wheelchair Options/AccessoriesLocal determinationTakes effect soonL33792CGS Administrators, LLCUpdated Oct 30, 2026
- Incision and Drainage (I & D) of Abscess of Skin, Subcutaneous and Accessory StructuresLocal determinationIn effectL33563Wellpoint FederalUpdated Jul 14, 2026
- Dialysis Access MaintenanceLocal determinationIn effectL34062CGS Administrators, LLCUpdated Feb 20, 2026
- Non-Invasive Peripheral Venous Vascular and Hemodialysis Access StudiesLocal determinationIn effectL35751WPS Insurance CorporationUpdated Feb 20, 2026
- Wheelchair Options/AccessoriesProposed local determinationProposedDL33792CGS Administrators, LLCUpdated Feb 13, 2026
- Wheelchair Options/AccessoriesLocal determinationIn effectL33792CGS Administrators, LLCUpdated Oct 23, 2025
- Hospital Beds And AccessoriesLocal determinationIn effectL33820CGS Administrators, LLCUpdated Feb 13, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Access", any status and sponsor, newest update first.
- Evaluation of a Novel Drain Stripping Device for Reducing Surgical Drain ComplicationsEnrolling by invitation
Mayo ClinicAcademic, hospital or other
NCT07119112 · 500 participants (planned) · Start Feb 20, 2026 · Primary completion Nov 2027
Device: Surgical drain stripping device · For: Surgical Drain; Abdominal Surgery Patients; Drains
Sites: Rochester, Minnesota
2,700 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Access", and for the whole product code for context.
This brand
24,146 reports: 15,953 malfunction, 7,650 injury, 516 death
Whole product code MSW
82 reports: 75 malfunction, 6 injury, 0 death
Newest reports for this brand
2124215-2026-57718 · Received Oct 30, 2026 · Event dated Oct 28, 2026
Device type: Catheter, Percutaneous (DQY)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Cardiac Arrest; Low Blood Pressure/ Hypotension; Low Cardiac Output; Thromboembolism; Thrombosis/Thrombus
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Access Thyroglobulin assay, a simultaneous one-step immunoenzymatic assay, Catalog Number 33860Open, Classified
Z-2322-2025 · Started Jul 10, 2025 · Posted by FDA Aug 13, 2025
Reason given: Access Thyroglobulin reagent lot 439163 may generate erroneously high patient results. Falsely increased Access Thyroglobulin results may lead a physician to pursue unnecessary diagnostic imaging studies and/or inappropriate therapy adjustments in patients being monitored for residual or recurrent thyroid cancer.
Cause as FDA categorized it: Under Investigation by firm · Device type: System, Test, Thyroglobulin (MSW)
5 more recall records with a free account
Published research
The most relevant PubMed records for "Access"[tiab]. The summary above synthesizes these.
- Arteriovenous Access for Hemodialysis: A Review.
Lok CE, Huber TS, Orchanian-Cheff A, et al. · JAMA · 2024Research Support, Non-U.S. Gov't, Review
- Hemodialysis Vascular Access: Core Curriculum 2025.
Lok CE, Yuo T, Lee T · Am J Kidney Dis · 2025Review
- Assessing healthcare access using the Levesque's conceptual framework- a scoping review.
Cu A, Meister S, Lefebvre B, et al. · Int J Equity Health · 2021Research Support, Non-U.S. Gov't, Scoping Review
- Pediatric hemodialysis access.
Almond PS, Emran MA, Koehler SM, et al. · Semin Pediatr Surg · 2021
- Access Cavity Preparations: Classification and Literature Review of Traditional and Minimally Invasive Endodontic Access Cavity Designs.
Shabbir J, Zehra T, Najmi N, et al. · J Endod · 2021Review
- Which endodontic access cavity is best? A literature review.
Al-Helou N, Zaki AA, Al Agha M, et al. · Br Dent J · 2023Review
- Improving access: modifying Penchansky and Thomas's Theory of Access.
Saurman E · J Health Serv Res Policy · 2016Research Support, Non-U.S. Gov't
- Upper Extremity Vascular Access.
Babunashvili AM, Bertrand OF, Ouarrak S · Interv Cardiol Clin · 2025Review
- Open-access.com.
Hudzik B, Polonski L · Int J Cardiol · 2014Letter
- Open access publishing, article downloads, and citations: randomised controlled trial.
Davis PM, Lewenstein BV, Simon DH, et al. · BMJ · 2008Research Support, Non-U.S. Gov't
- Transradial intervention: basics.
Patel A, Naides AI, Patel R, et al. · J Vasc Interv Radiol · 2015Video-Audio Media
- Surgical Approach to Hemodialysis Access.
Rowse JW, Kirksey L · Semin Intervent Radiol · 2016Review
Other devices of this type
Also filed under product code MSW.
- Atellica IM Thyroglobulin (Tg)Siemens Healthcare Diagnostics, Inc. · 510(k) 2025
- Elecsys Tg IIRoche Diagnostics · 510(k) 2023
- Brahms Diagnostica Dynotest Tg-PlusBrahms Diagnostica, LLC · 510(k) 2002
- Nichols Advantage ThyroglobNichols Institute Diagnostics · 510(k) 2000
- Nichols Chemiluminescence Thyroglobulin, Model 60-4240Nichols Institute Diagnostics · 510(k) 2000
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.